(Q43461452)

14 July 2018

title

Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. (English)

1 reference

14 July 2018

0 references

0 references

1 reference

M Colafigli

1

0 references

author name string

C Torti

2

1 reference

14 July 2018

E M Trecarichi

3

1 reference

14 July 2018

L Albini

4

1 reference

14 July 2018

A Rosi

5

1 reference

14 July 2018

V Micheli

6

1 reference

14 July 2018

N Manca

7

1 reference

14 July 2018

G Penco

8

1 reference

14 July 2018

B Bruzzone

9

1 reference

14 July 2018

G Punzi

10

1 reference

14 July 2018

P Corsi

11

1 reference

14 July 2018

G Parruti

12

1 reference

14 July 2018

P Bagnarelli

13

1 reference

14 July 2018

L Monno

14

1 reference

14 July 2018

A Gonnelli

15

1 reference

14 July 2018

R Cauda

16

1 reference

14 July 2018

S Di Giambenedetto

17

1 reference

14 July 2018

ARCA, UCSC and Brescia HIV resistance study groups

18

1 reference

14 July 2018

language of work or name

1 reference

27 April 2012

1 reference

14 July 2018

Clinical Microbiology and Infection

published in

1 reference

14 July 2018

volume

18

1 reference

14 July 2018

issue

8

1 reference

14 July 2018

page(s)

E299-304

1 reference

14 July 2018

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

The effect of transmitted HIV-1 drug resistance on pre-therapy viral load

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Class-sparing regimens for initial treatment of HIV-1 infection

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

Transmitted HIV Type 1 Drug Resistance and Non-B Subtypes Prevalence among Seroconverters and Newly Diagnosed Patients from 1992 to 2005 in Italy

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029625

10.1111/J.1469-0691.2012.03847.X

1 December 2018

Identifiers

DOI

1 reference

14 July 2018

PMC publication ID

6029625

1 reference

14 July 2018

PubMed publication ID

22536753

1 reference

14 July 2018